United Kingdom · Series D startup
4 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$111Mraised across 4 rounds since 2011, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEs
Novartis Venture Fund
Global Life Science Ventures
Consort MedicalFrom a historical funding record
Novartis Venture Fund
EQT life science
YFM Equity PartnersConsort MedicalFrom a historical funding record
Atlas Genetics filed 7 raises, $40M in all. Filings say how much was sold and to how many investors; they never name the investors.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Novartis Venture FundConsort MedicalEQT life scienceYFM Equity PartnersJohnson & Johnson InnovationGlobal Life Science VenturesJohnson & Johnson Robotics and Digital SolutionsSOUTH WEST VENTURES FUNDMissing a round, or an investor who was in one? Tell us.
Atlas Genetics's investors include BB Biotech Ventures, Novartis Venture Fund, Consort Medical, Johnson & Johnson Development Corporation (JJDC) and EQT life science, and 7 more on record.
Atlas Genetics has raised $111M across 4 rounds since 2011.
Atlas Genetics's most recent round was a Series D of $35M in Jan 2017.
Its most recent round, $35M in Jan 2017, is also its largest on record.
Atlas Genetics's first round on record, in Jul 2011, was backed by Novartis Venture Fund, Johnson & Johnson Development Corporation (JJDC) and EQT life science and 2 others.
Atlas Genetics's latest named round is a Series D, in Jan 2017.
Atlas Genetics is based in the United Kingdom.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
